Subscribe to RoboticOncology.com RSS Feed

Fast-Track For Cancer Drugs

This site requires Flash Player version 10.1 or higher. You can install the latest version of the Adobe Flash Player by clicking here.

Fox News, 06/10/2012

Fox 5 Medical A-Team member and prostate cancer expert, discusses newly announced federal guidelines designed to fast-track the approval of new cancer drug therapies, including the treatment of prostate cancer and breast cancer. In this new wave of medicine, drugs are being designed to target genetic factors as well as fortify the body’s own cancer-fighting abilities. New cancer treatments could also become more affordable as the lengthy and costly approval process is improved.
www.roboticoncology.com

Views: 1905

Back to Videos


Bookmark Using:
Facebook Twitter LinkedIn Email Yahoo

Share on Facebook

Call to Make an Appointment With Dr. David Samadi:

1-212-365-5000

Click the contact link to learn how Dr. Samadi can help treat your prostate cancer and give you back your quality of life.

* The benefits of robotic surgery cannot be guaranteed as surgery is both patient and procedure specific. Previous surgical results do not guarantee future outcomes.




Testimonials
Avi S, Israel

more..
Jeannette B., Netherlands (en)

In 2008 my husband was diagnosed with Prostate cancer with a PSA of 31.8 and a Gleason Score of 9. When we first got the news we immediately began to research different doctors and new techniques in our home country of the Netherlands and throughout Europe.

more..
D. McGuire, Suffern, New York

"In full recognition of my panicked state his office made arrangements for my wife and I to meet with him that same day. We knew immediately we found who we were looking for..."

more..
Κ. β., Greece, Athens

Υγιης πλεον συνεχιζω ολες τις δραστηριοτητες μου.Εγω,η συζυγος μου και τα παιδια μας,σας ευγνωμονουμε.Σας ΕΥΧΑΡΙΣΤΩ πολυ-πολυ,εσας και ολους τους εξαιρετικους συνεργατες σας. Σας ενημερωνω επισης, οτι στις 11 Φεβρουαριου 2010 εκανα και το δευτερο Τest P.S.A.:0,02 ng/ml...

more..